Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Apocyni veneti folium extract is a natural product derived from the leaves of *Apocynum venetum* L., a plant in the Apocynaceae family commonly known as Luobumaye in Traditional Chinese Medicine. The extract is characterized by a high concentration of bioactive flavonoids, including quercetin, rutin, isoquercetin, hyperoside, and kaempferol, alongside organic acids and amino acids. It is primarily researched for its cardioprotective, antihypertensive, and neuroprotective properties. Mechanistically, the extract has been shown to modulate the PI3K/Akt/GSK-3β and AMPK signaling pathways, inhibit acetylcholinesterase (AChE) activity, and reduce oxidative stress and neuroinflammation. Recent studies highlight its potential in mitigating Alzheimer's disease pathology by targeting the gut-brain axis and reducing amyloid-β accumulation. It is typically utilized as a dietary supplement or traditional herbal remedy rather than a regulated pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on apocyni veneti folium extract.